Together, human blood and mouse brain samples with a SOD1 mutation in the same position seem to converge on the same molecular dysfunction (i.e., impaired ATF3 signaling) within the context of ALS. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.